Published in Cancer on February 15, 2006
Cognitive Health Research on Musical Arts (CHROMA) | NCT04137913
Neuroendocrine-immune mechanisms of behavioral comorbidities in patients with cancer. J Clin Oncol (2008) 3.30
Behavioral symptoms in patients with breast cancer and survivors. J Clin Oncol (2008) 2.38
Phase III, randomized, double-blind, placebo-controlled study of long-acting methylphenidate for cancer-related fatigue: North Central Cancer Treatment Group NCCTG-N05C7 trial. J Clin Oncol (2010) 2.28
Inflammation and behavioral symptoms after breast cancer treatment: do fatigue, depression, and sleep disturbance share a common underlying mechanism? J Clin Oncol (2011) 2.05
Physical and psychosocial recovery in the year after primary treatment of breast cancer. J Clin Oncol (2011) 1.97
Possible socioeconomic and ethnic disparities in quality of life in a cohort of breast cancer survivors. Breast Cancer Res Treat (2007) 1.84
One-year outcomes of a behavioral therapy intervention trial on sleep quality and cancer-related fatigue. J Clin Oncol (2009) 1.81
A comparison of the characteristics of disease-free breast cancer survivors with or without cancer-related fatigue syndrome. Eur J Cancer (2008) 1.52
Quality of life, fatigue and depression in Italian long-term breast cancer survivors. Support Care Cancer (2012) 1.49
Wisconsin Ginseng (Panax quinquefolius) to improve cancer-related fatigue: a randomized, double-blind trial, N07C2. J Natl Cancer Inst (2013) 1.47
Cancer-related fatigue: links with inflammation in cancer patients and survivors. Brain Behav Immun (2007) 1.42
The Women's wellness after cancer program: a multisite, single-blinded, randomised controlled trial protocol. BMC Cancer (2017) 1.41
Cancer-related fatigue and its associations with depression and anxiety: a systematic review. Psychosomatics (2009) 1.40
Cytokine gene polymorphisms and fatigue in breast cancer survivors: early findings. Brain Behav Immun (2008) 1.36
Inflammation and cancer-related fatigue: mechanisms, contributing factors, and treatment implications. Brain Behav Immun (2012) 1.36
Online tool to guide decisions for BRCA1/2 mutation carriers. J Clin Oncol (2012) 1.35
Utility of a cognitive-behavioral model to predict fatigue following breast cancer treatment. Health Psychol (2007) 1.29
Cancer-related fatigue--mechanisms, risk factors, and treatments. Nat Rev Clin Oncol (2014) 1.29
Fatigue after treatment for early stage breast cancer: a controlled comparison. Cancer (2007) 1.28
Pilot study of Panax quinquefolius (American ginseng) to improve cancer-related fatigue: a randomized, double-blind, dose-finding evaluation: NCCTG trial N03CA. Support Care Cancer (2009) 1.28
Physical activity, long-term symptoms, and physical health-related quality of life among breast cancer survivors: a prospective analysis. J Cancer Surviv (2007) 1.27
Identifying clinically meaningful fatigue with the Fatigue Symptom Inventory. J Pain Symptom Manage (2008) 1.21
Psychological intervention and health outcomes among women treated for breast cancer: a review of stress pathways and biological mediators. Brain Behav Immun (2008) 1.17
Fatigue states after cancer treatment occur both in association with, and independent of, mood disorder: a longitudinal study. BMC Cancer (2006) 1.16
The Fatigue Symptom Inventory: a systematic review of its psychometric properties. Support Care Cancer (2010) 1.16
Community-based exercise program effectiveness and safety for cancer survivors. J Cancer Surviv (2012) 1.16
Factors affecting quality of life in cancer patients undergoing chemotherapy. Afr Health Sci (2011) 1.15
A randomised, placebo-controlled, double-blind trial of the effects of d-methylphenidate on fatigue and cognitive dysfunction in women undergoing adjuvant chemotherapy for breast cancer. Support Care Cancer (2007) 1.13
Quality of Life in Cancer Patients undergoing Chemotherapy. Oman Med J (2009) 1.12
Recommendations for high-priority research on cancer-related fatigue in children and adults. J Natl Cancer Inst (2013) 1.11
Direct and buffering effects of social support among gynecologic cancer survivors. Ann Behav Med (2010) 1.07
Yoga's impact on inflammation, mood, and fatigue in breast cancer survivors: a randomized controlled trial. J Clin Oncol (2014) 1.07
Fatigue, inflammation, and ω-3 and ω-6 fatty acid intake among breast cancer survivors. J Clin Oncol (2012) 1.05
Yoga for persistent fatigue in breast cancer survivors: results of a pilot study. Evid Based Complement Alternat Med (2011) 1.04
Development of a mouse model for assessing fatigue during chemotherapy. Comp Med (2011) 1.02
Relaxation acupressure reduces persistent cancer-related fatigue. Evid Based Complement Alternat Med (2010) 1.01
Cognitive behaviour therapy for fatigued cancer survivors: long-term follow-up. Br J Cancer (2007) 1.01
Validation of a questionnaire measuring the regulation of autonomic function. BMC Complement Altern Med (2008) 0.99
Sympathetic and parasympathetic activity in cancer-related fatigue: more evidence for a physiological substrate in cancer survivors. Psychoneuroendocrinology (2011) 0.99
Predictors and course of chronic fatigue in long-term breast cancer survivors. J Cancer Surviv (2010) 0.98
Fatigue after treatment in breast cancer survivors: prevalence, determinants and impact on health-related quality of life. Support Care Cancer (2011) 0.97
Does chemotherapy really affect the quality of life of women with breast cancer? J Breast Cancer (2013) 0.96
Cancer survivors' responses to daily stressors: implications for quality of life. Health Psychol (2012) 0.96
Three versus six months of exercise training in breast cancer survivors. Breast Cancer Res Treat (2010) 0.96
A pan-Canadian practice guideline and algorithm: screening, assessment, and supportive care of adults with cancer-related fatigue. Curr Oncol (2013) 0.96
Applying a conceptual model for examining health-related quality of life in long-term breast cancer survivors: CALGB study 79804. Psychooncology (2008) 0.95
A clinically translatable mouse model for chemotherapy-related fatigue. Comp Med (2013) 0.94
Distress screening remains important during follow-up after primary breast cancer treatment. Support Care Cancer (2013) 0.94
Fatigue and herpesvirus latency in women newly diagnosed with breast cancer. Brain Behav Immun (2011) 0.93
Prolonged impact of chemotherapy on fatigue in breast cancer survivors: a longitudinal comparison with radiotherapy-treated breast cancer survivors and noncancer controls. Cancer (2011) 0.93
Factors predicting clinically significant fatigue in women following treatment for primary breast cancer. Support Care Cancer (2010) 0.92
Child maltreatment and breast cancer survivors: social support makes a difference for quality of life, fatigue and cancer stress. Eur J Cancer (2012) 0.92
Breast Cancer and Fatigue. Sleep Med Clin (2008) 0.91
A comparison of cognitive function, sleep and activity levels in disease-free breast cancer patients with or without cancer-related fatigue syndrome. BMJ Support Palliat Care (2012) 0.91
The effect of cigarette smoking on cancer treatment-related side effects. Oncologist (2011) 0.90
Health-related quality of life and biomarkers in breast cancer survivors participating in tai chi chuan. J Cancer Surviv (2011) 0.90
Physical activity and fatigue in breast cancer survivors: a panel model examining the role of self-efficacy and depression. Cancer Epidemiol Biomarkers Prev (2013) 0.89
Physical activity type and intensity among rural breast cancer survivors: patterns and associations with fatigue and depressive symptoms. J Cancer Surviv (2010) 0.89
The role of IL-1β and TNF-α signaling in the genesis of cancer treatment related symptoms (CTRS): a study using cytokine receptor-deficient mice. Brain Behav Immun (2014) 0.89
The anticancer agent doxorubicin disrupts mitochondrial energy metabolism and redox balance in skeletal muscle. Free Radic Biol Med (2013) 0.88
Spore Powder of Ganoderma lucidum Improves Cancer-Related Fatigue in Breast Cancer Patients Undergoing Endocrine Therapy: A Pilot Clinical Trial. Evid Based Complement Alternat Med (2011) 0.87
Cancer-related intrusive thoughts predict behavioral symptoms following breast cancer treatment. Health Psychol (2013) 0.87
Sequelae of breast cancer and the influence of menopausal status at diagnosis among rural breast cancer survivors. J Womens Health (Larchmt) (2011) 0.87
Sedentary behavior, health-related quality of life, and fatigue among breast cancer survivors. J Phys Act Health (2012) 0.86
A longitudinal study of depression, fatigue, and sleep disturbances as a symptom cluster in women with breast cancer. J Pain Symptom Manage (2014) 0.86
Prevalence of fatigue among cancer patients receiving various anticancer therapies and its impact on quality of life: a cross-sectional study. Indian J Palliat Care (2012) 0.85
Quantifying fatigue in (long-term) colorectal cancer survivors: a study from the population-based patient reported outcomes following initial treatment and long term evaluation of survivorship registry. Eur J Cancer (2013) 0.85
Evaluation of the psychometric properties of the BCPT Symptom Checklist with a sample of breast cancer patients before and after adjuvant therapy. Psychooncology (2010) 0.85
Psychological and immunological characteristics of fatigued women undergoing radiotherapy for early-stage breast cancer. Support Care Cancer (2012) 0.85
A randomized, double-blind, placebo-controlled study of oral coenzyme Q10 to relieve self-reported treatment-related fatigue in newly diagnosed patients with breast cancer. J Support Oncol (2013) 0.85
Fatigue and sleep during cancer and chemotherapy: translational rodent models. Comp Med (2008) 0.85
The evolution of mindfulness-based physical interventions in breast cancer survivors. Evid Based Complement Alternat Med (2012) 0.85
Relationships between cardiorespiratory fitness, physical activity, and psychosocial variables in overweight and obese breast cancer survivors. Int J Behav Med (2010) 0.84
Health-related quality of life in long-term breast cancer survivors: differences by adjuvant chemotherapy dose in Cancer and Leukemia Group B study 8541. Cancer (2009) 0.84
Impact of partial versus whole breast radiation therapy on fatigue, perceived stress, quality of life and natural killer cell activity in women with breast cancer. BMC Cancer (2012) 0.83
Trajectories of Evening Fatigue in Oncology Outpatients Receiving Chemotherapy. J Pain Symptom Manage (2015) 0.83
Preliminary Development and Evaluation of an Algorithm to Identify Breast Cancer Chemotherapy Toxicities Using Electronic Medical Records and Administrative Data. J Oncol Pract (2014) 0.83
Effect of pretreatment distress on daily fatigue after chemotherapy for breast cancer. J Oncol Pract (2008) 0.82
Fatigue-based subgroups of breast cancer survivors with insomnia. Cancer Nurs (2009) 0.82
Impact of Inflammation on Myeloproliferative Neoplasm Symptom Development. Mediators Inflamm (2015) 0.82
Breast cancer survivorship issues. Hematol Oncol Clin North Am (2013) 0.82
Returning to work after sick leave due to cancer: a 365-day cohort study of Japanese cancer survivors. J Cancer Surviv (2015) 0.81
Quality of life over 5 years after a breast cancer diagnosis among low-income women: effects of race/ethnicity and patient-physician communication. Cancer (2014) 0.81
Prevalence, predictors, and prognostic impact of fatigue among Brazilian outpatients with advanced cancers. Support Care Cancer (2012) 0.81
Variation in fatigue among 6011 (long-term) cancer survivors and a normative population: a study from the population-based PROFILES registry. Support Care Cancer (2015) 0.81
Low heart rate variability and cancer-related fatigue in breast cancer survivors. Psychoneuroendocrinology (2014) 0.81
Longitudinal relationships between fatigue and depression in cancer patients with depression and/or pain. Health Psychol (2012) 0.81
Exercise, inflammation, and fatigue in cancer survivors. Exerc Immunol Rev (2016) 0.81
Validation of the State Version Questionnaire on Autonomic Regulation (State-aR) for cancer patients. Eur J Med Res (2011) 0.80
Development of a questionnaire to assess the determinants of exercise among breast cancer survivors in Puerto Rico. Physiother Theory Pract (2012) 0.80
The role of physical activity and physical fitness in postcancer fatigue: a randomized controlled trial. Support Care Cancer (2013) 0.79
Management of unexplained symptoms in survivors of cancer. J Oncol Pract (2010) 0.79
Quality of life in cancer patients undergoing chemotherapy in a tertiary care center in malwa region of punjab. Indian J Palliat Care (2014) 0.78
Thyrotropin-releasing hormone as a treatment for cancer-related fatigue: a randomized controlled study. Support Care Cancer (2011) 0.78
Assessment of daily and weekly fatigue among African American cancer survivors. J Psychosoc Oncol (2013) 0.77
Magnetic resonance spectroscopic imaging and volumetric measurements of the brain in patients with postcancer fatigue: a randomized controlled trial. PLoS One (2013) 0.77
Behavioral Symptoms after Breast Cancer Treatment: A Biobehavioral Approach. J Pers Med (2015) 0.77
Health states of women after conservative surgery and radiation for breast cancer. Breast Cancer Res Treat (2009) 0.77
Comparison of Pharmaceutical, Psychological, and Exercise Treatments for Cancer-Related Fatigue: A Meta-analysis. JAMA Oncol (2017) 0.76
Attachment style and respiratory sinus arrhythmia predict post-treatment quality of life in breast cancer survivors. Psychooncology (2014) 0.76
Collaborative care management of late-life depression in the primary care setting: a randomized controlled trial. JAMA (2002) 15.53
Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA (2008) 13.35
Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality. JAMA (2010) 8.93
Riding the crest of the teachable moment: promoting long-term health after the diagnosis of cancer. J Clin Oncol (2005) 7.57
American Society of Clinical Oncology identifies five key opportunities to improve care and reduce costs: the top five list for oncology. J Clin Oncol (2012) 7.16
Update of the National Surgical Adjuvant Breast and Bowel Project Study of Tamoxifen and Raloxifene (STAR) P-2 Trial: Preventing breast cancer. Cancer Prev Res (Phila) (2010) 5.81
Cancer survivors in the United States: age, health, and disability. J Gerontol A Biol Sci Med Sci (2003) 5.22
Quality of life in long-term, disease-free survivors of breast cancer: a follow-up study. J Natl Cancer Inst (2002) 5.19
Longer therapy, iatrogenic amenorrhea, and survival in early breast cancer. N Engl J Med (2010) 5.17
Health behaviors of cancer survivors: examining opportunities for cancer control intervention. J Clin Oncol (2005) 4.10
Sleep difficulty in women at midlife: a community survey of sleep and the menopausal transition. Menopause (2003) 3.57
Common breast cancer-predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers. Am J Hum Genet (2008) 3.41
Cancer survivors in the United States: prevalence across the survivorship trajectory and implications for care. Cancer Epidemiol Biomarkers Prev (2013) 3.40
Cancer survivors: a booming population. Cancer Epidemiol Biomarkers Prev (2011) 3.33
Perceptions of patients and physicians regarding phase I cancer clinical trials: implications for physician-patient communication. J Clin Oncol (2003) 3.31
Robustness of a multivariate normal approximation for imputation of incomplete binary data. Stat Med (2007) 3.26
Rapid-learning system for cancer care. J Clin Oncol (2010) 3.13
Differences between primary care physicians' and oncologists' knowledge, attitudes and practices regarding the care of cancer survivors. J Gen Intern Med (2011) 3.11
Long-term survivors of childhood cancers in the United States. Cancer Epidemiol Biomarkers Prev (2009) 3.04
Cancer as a risk factor for long-term cognitive deficits and dementia. J Natl Cancer Inst (2005) 3.02
Validity of cancer registry data for measuring the quality of breast cancer care. J Natl Cancer Inst (2002) 3.00
Fatigue and proinflammatory cytokine activity in breast cancer survivors. Psychosom Med (2002) 2.96
Adjuvant chemotherapy use and adverse events among older patients with stage III colon cancer. JAMA (2010) 2.93
Beyond the development of quality-of-life instruments: where do we go from here? J Clin Oncol (2002) 2.81
Understanding cancer patients' experience and outcomes: development and pilot study of the Cancer Care Outcomes Research and Surveillance patient survey. Support Care Cancer (2006) 2.73
Inflammatory biomarkers for persistent fatigue in breast cancer survivors. Clin Cancer Res (2006) 2.69
Quality of life at the end of primary treatment of breast cancer: first results from the moving beyond cancer randomized trial. J Natl Cancer Inst (2004) 2.66
Benefit from exemestane as extended adjuvant therapy after 5 years of adjuvant tamoxifen: intention-to-treat analysis of the National Surgical Adjuvant Breast And Bowel Project B-33 trial. J Clin Oncol (2008) 2.55
Quality of life, fertility concerns, and behavioral health outcomes in younger breast cancer survivors: a systematic review. J Natl Cancer Inst (2012) 2.49
A population-based assessment of specialty physician involvement in cancer clinical trials. J Natl Cancer Inst (2011) 2.48
Clinical Cancer Advances 2005: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology. J Clin Oncol (2005) 2.47
Pretest prediction of BRCA1 or BRCA2 mutation by risk counselors and the computer model BRCAPRO. J Natl Cancer Inst (2002) 2.45
A randomized trial of medical care with and without physical therapy and chiropractic care with and without physical modalities for patients with low back pain: 6-month follow-up outcomes from the UCLA low back pain study. Spine (Phila Pa 1976) (2002) 2.40
Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk. PLoS Genet (2013) 2.39
Delivering high-quality and affordable care throughout the cancer care continuum. J Clin Oncol (2013) 2.39
A qualitative report of patient problems and postoperative instructions. J Oral Maxillofac Surg (2005) 2.34
Barriers to breast and colorectal cancer survivorship care: perceptions of primary care physicians and medical oncologists in the United States. J Clin Oncol (2013) 2.32
Neurocognitive performance in breast cancer survivors exposed to adjuvant chemotherapy and tamoxifen. J Clin Exp Neuropsychol (2004) 2.24
Multiple cancer prevalence: a growing challenge in long-term survivorship. Cancer Epidemiol Biomarkers Prev (2007) 2.21
Altered frontocortical, cerebellar, and basal ganglia activity in adjuvant-treated breast cancer survivors 5-10 years after chemotherapy. Breast Cancer Res Treat (2006) 2.17
Patients' experiences with care for lung cancer and colorectal cancer: findings from the Cancer Care Outcomes Research and Surveillance Consortium. J Clin Oncol (2010) 2.16
A comparison of imputation methods in a longitudinal randomized clinical trial. Stat Med (2005) 2.10
Diurnal cortisol rhythm and fatigue in breast cancer survivors. Psychoneuroendocrinology (2005) 2.08
Inflammation and behavioral symptoms after breast cancer treatment: do fatigue, depression, and sleep disturbance share a common underlying mechanism? J Clin Oncol (2011) 2.05
Can't see the forest for the care plan: a call to revisit the context of care planning. J Clin Oncol (2013) 2.04
Long-term prognostic role of functional limitations among women with breast cancer. J Natl Cancer Inst (2010) 2.04
Physician roles in the cancer-related follow-up care of cancer survivors. Fam Med (2013) 2.00
Cancer survivorship: a new challenge in delivering quality cancer care. J Clin Oncol (2006) 1.99
Cognitive impairment associated with chemotherapy for cancer: report of a workshop. J Clin Oncol (2004) 1.97
Physical and psychosocial recovery in the year after primary treatment of breast cancer. J Clin Oncol (2011) 1.97
Trends and advances in cancer survivorship research: challenge and opportunity. Semin Radiat Oncol (2003) 1.94
Inflammatory biomarkers and fatigue during radiation therapy for breast and prostate cancer. Clin Cancer Res (2009) 1.93
The BCPT symptom scales: a measure of physical symptoms for women diagnosed with or at risk for breast cancer. J Natl Cancer Inst (2005) 1.92
Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction. Cancer Res (2010) 1.90
Imputation and variable selection in linear regression models with missing covariates. Biometrics (2005) 1.90
A national framework for cancer surveillance in the United States. Cancer Causes Control (2005) 1.89
Cognitive complaints after breast cancer treatments: examining the relationship with neuropsychological test performance. J Natl Cancer Inst (2013) 1.86
Recovery issues in cancer survivorship: a new challenge for supportive care. Cancer J (2006) 1.86
Forgoing medical care because of cost: assessing disparities in healthcare access among cancer survivors living in the United States. Cancer (2010) 1.85
Community-partnered cluster-randomized comparative effectiveness trial of community engagement and planning or resources for services to address depression disparities. J Gen Intern Med (2013) 1.85
Cancer survivorship: a new challenge in comprehensive cancer control. Cancer Causes Control (2005) 1.85
Possible socioeconomic and ethnic disparities in quality of life in a cohort of breast cancer survivors. Breast Cancer Res Treat (2007) 1.84
Cancer patients' roles in treatment decisions: do characteristics of the decision influence roles? J Clin Oncol (2010) 1.84
Cancer survivorship research among ethnic minority and medically underserved groups. Oncol Nurs Forum (2002) 1.84
Patient-reported outcomes assessment in cancer trials: taking stock, moving forward. J Clin Oncol (2007) 1.84
Parental cancer and the family: a population-based estimate of the number of US cancer survivors residing with their minor children. Cancer (2010) 1.83
Association of breast cancer and its therapy with menopause-related symptoms. Menopause (2004) 1.81
Receipt of psychosocial care among cancer survivors in the United States. J Clin Oncol (2013) 1.79
Neurotoxicity from oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: NSABP C-07. J Clin Oncol (2007) 1.77
Are primary care providers prepared to care for survivors of breast cancer in the safety net? Cancer (2014) 1.77
The role of obesity in cancer survival and recurrence. Cancer Epidemiol Biomarkers Prev (2012) 1.75
Adjuvant tamoxifen prescription in women 65 years and older with primary breast cancer. J Clin Oncol (2002) 1.75
Exploring nonresponse bias in a health survey using neighborhood characteristics. Am J Public Health (2009) 1.71
Survivorship care planning after the institute of medicine recommendations: how are we faring? J Cancer Surviv (2011) 1.69
The importance of social context: neighborhood stressors, stress-buffering mechanisms, and alcohol, drug, and mental health disorders. Soc Sci Med (2007) 1.68
Patient-centered cancer treatment planning: improving the quality of oncology care. Summary of an Institute of Medicine workshop. Oncologist (2011) 1.67
Yoga for persistent fatigue in breast cancer survivors: a randomized controlled trial. Cancer (2011) 1.67
Clinical cancer advances 2006: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology. J Clin Oncol (2006) 1.64
Multiple imputation using an iterative hot-deck with distance-based donor selection. Stat Med (2008) 1.64
A teachable moment for oncologists: cancer survivors, 10 million strong and growing! J Clin Oncol (2005) 1.62
Do increases in the market share of managed care influence quality of cancer care in the fee-for-service sector? J Natl Cancer Inst (2005) 1.62
The impact of cancer and quality of life for long-term survivors. Psychooncology (2008) 1.61
The LIVESTRONG Survivorship Center of Excellence Network. J Cancer Surviv (2009) 1.60
Breast cancer chemoprevention phase I evaluation of biomarker modulation by arzoxifene, a third generation selective estrogen receptor modulator. Clin Cancer Res (2004) 1.58
Mental health service use among adult cancer survivors: analyses of the National Health Interview Survey. J Clin Oncol (2002) 1.57
Amenorrhea in premenopausal women on the doxorubicin-and-cyclophosphamide-followed-by-docetaxel arm of NSABP B-30 trial. Breast Cancer Res Treat (2008) 1.56
Population-based survivorship research using cancer registries: a study of non-Hodgkin's lymphoma survivors. J Cancer Surviv (2007) 1.56
Cardiovascular risk factors among long-term survivors of breast, prostate, colorectal, and gynecologic cancers: a gap in survivorship care? J Cancer Surviv (2013) 1.55
Quality of care for childhood attention-deficit/hyperactivity disorder in a managed care medicaid program. J Am Acad Child Adolesc Psychiatry (2010) 1.55
Predictive impact of circulating vascular endothelial growth factor in four phase III trials evaluating bevacizumab. Clin Cancer Res (2012) 1.54
Project Masihambisane: a cluster randomised controlled trial with peer mentors to improve outcomes for pregnant mothers living with HIV. Trials (2011) 1.54